Luciana Borio (Susan Walsh/AP Images)

Bob Nelsen's ARCH adds FDA, biode­fense ex­per­tise with ap­point­ment of Lu­ciana Bo­rio

Once vet­ted by the Biden team to lead the FDA as com­mis­sion­er, Lu­ciana Bo­rio is now com­pil­ing quite the ré­sumé.

Bo­rio has now been named a ven­ture part­ner at Bob Nelsen’s ARCH Ven­ture Part­ners, and Nelsen told End­points News, “She will be in­volved in projects across the port­fo­lio, in­clud­ing on­go­ing projects in man­u­fac­tur­ing, clin­i­cal tri­als, gene ther­a­py and gene edit­ing, cell ther­a­py, and de­liv­ery. We are ex­plor­ing mul­ti­ple projects in in­fec­tious dis­ease, and next gen­er­a­tion man­u­fac­tur­ing.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.